Vancomycin Hydrochloride for Injection recalled over temperature-control failures
- Recall date
- October 6, 2014
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Hospira Inc. recalls Vancomycin Hydrochloride for Injection, USP, 500 mg Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, R…
- Recall number
- D-0387-2015
- FDA classification
- Class II
- Brand / firm
- Hospira Inc.
- Sold / distributed
- Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of the distributor and were not further distributed. Distribut…
Why it was recalled
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Vancomycin Hydrochloride for Injection, USP, 500 mg Sterile Powder per Fliptop Vial, packaged in 10 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4332-01.
Get recall alerts
Free email alert whenever Hospira Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hospira Inc.